Used primarily in the treatment of Alzheimer's disease, this compound functions as a cholinesterase inhibitor, helping to increase acetylcholine levels in the brain. It improves cognitive function by enhancing cholinergic neurotransmission, which is typically impaired in neurodegenerative conditions. Due to its ability to cross the blood-brain barrier effectively, it has been studied extensively for symptomatic management of mild to moderate dementia. Additionally, derivatives of this compound serve as templates in developing new neuroactive agents and are investigated for their potential in targeting other neurological disorders.